Bristol-Myers Squibb said on Wednesday its experimental drug helped reduce the severity of the most common form of psoriasis in a mid-stage trial.

https://ift.tt/2Oc63j3 support@endlesssupplies.biz (Endless Supplies .Biz) September 12, 2018 at 01:50AM
No comments:
Post a Comment